Keytruda’s sales are gaining from rapid uptake across earlier-stage indications, mainly early-stage non-small cell lung ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...

"We're very confident that this approach may offer us a new cure for lung cancer," says researcher and Project Manager ... This is nanoscale—so small that as many as 100 nanocapsules, containing the ...

Genprex (GNPX) announced it has entered into an exclusive license agreement with the University of Michigan, granting Genprex a worldwide, ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

She didn't smoke but got advanced lung cancer. Genetic testing opened the door to targeted therapies. South Carolina doesn't ...

KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, is indicated for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC), with no EGFR ...

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

Tuesday said its Phase 3 study evaluating subcutaneous Keytruda with Alteogen Inc.'s berahyaluronidase alfa in ...